Subcutaneous defibrillator implantation without fluoroscopy

• US 8,145,305 B2
• Filed: 09/05/2011
• Issued: 03/27/2012
• Est. Priority Date: 09/18/2000
• Status: Expired due to Term

• Current Assignee: Cameron Incorporated (Schlumberger NV)
• Original Assignee: Cameron Incorporated (Schlumberger NV)
• Inventors: Ostroff, Alan H., Erlinger, Paul, Bardy, Gust H.
• Primary Examiner(s): Manuel, George
• Assistant Examiner(s): WIELAND, ROBERT N
• Application Number:
  US13/225,517
• Publication Number:
  US 20110313501A1
• Time in Patent Office: 204 Days
• Field of Search: 600/513, 607/5, 607/9, 607/119
• US Class Current: 607/9
• CPC Class Codes: A61N 1/375 Constructional arrangements, e.g. casings
• CPC Class Codes: A61N 1/37512 Pacemakers
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators
• CPC Class Codes: A61N 1/3906 characterised by the form of the shockwave
• CPC Class Codes: A61N 1/3918 characterised by shock pathway, e.g. by electrode configuration
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/3968 Constructional arrangements, e.g. casings A61N1/375 takes precedence
• CPC Class Codes: A61N 1/3975 Power supply A61N1/378 takes precedence

Abstract

A subcutaneous cardiac device includes a subcutaneous electrode and a housing coupled to the subcutaneous electrode by a lead with a lead wire. The subcutaneous electrode is adapted to be implanted in a frontal region of the patient so as to overlap a portion of the patient'"'"'s heart.

Claims

1. A method of surgically implanting an implantable subcutaneous defibrillator having one or more lead electrode assemblies and a canister in a patient comprising:

implanting the canister in a pectoral location, above and to the left of the heart under the collarbone on the anterior chest of the patient;

subcutaneously implanting a first lead electrode assembly having a first electrode such that the first electrode is implanted in a position generally parallel to and adjacent the sternum on the anterior chest of the patient;

without using fluoroscopy to implant the subcutaneous defibrillator; and

coupling the canister and the first lead electrode assembly.

2. The method of claim 1, further comprising subcutaneously implanting a second lead electrode assembly having a second electrode such that the second electrode is implanted in a position to the left of the heart, and coupling the second lead electrode assembly to the canister.

3. The method of claim 2, wherein each of the first and second electrodes is a generally curvelinear electrode having a length in the range of 2-10 centimeters and a diameter in the range of 1-5 millimeters, and wherein each of the first and second lead electrodes are implanted such that their length is generally parallel to the sternum of the patient.

4. The method of claim 2, wherein the canister is inactive, and the subcutaneous defibrillator is configured for therapy delivery between the first electrode and the second electrode.

5. The method of claim 2, wherein the canister is active, and the subcutaneous defibrillator is configured for therapy delivery using the following configurations:

between the canister and the first electrode;

between the canister and the second electrode; and

between the canister and both the first and second lead electrodes connected in common.

6. The method of claim 2, wherein at least one of the first lead electrode and the second lead electrode includes each of a shock delivery electrode and a separate sensing electrode.

7. The method of claim 1, wherein the first lead electrode comprises the first electrode as a shock electrode and at least one sensing electrode electrically isolated from the first electrode.

8. A method of surgically implanting an implantable subcutaneous defibrillator having one or more lead electrode assemblies and a canister in a patient comprising:

implanting the canister in a side position on the left side of the rib cage, under the arm;

subcutaneously implanting a first lead electrode assembly having a first electrode such that the first electrode is implanted in a position generally parallel to and adjacent the sternum on the anterior chest of the patient;

without using fluoroscopy to implant the subcutaneous defibrillator; and

coupling the canister and the first lead electrode assembly.

9. The method of claim 8, wherein the first electrode is a generally curvelinear electrode having a length in the range of 2-10 centimeters and a diameter in the range of 1-5 millimeters, and wherein the first lead electrode is implanted such that the length is generally parallel to the sternum of the patient.

10. The method of claim 8, wherein the first lead electrode includes each of a shock delivery electrode and a separate sensing electrode.

11. A method of surgically implanting an implantable subcutaneous defibrillator having one or more lead electrode assemblies and a canister in a patient comprising:

implanting the canister in a front position, under the inframammary crease, on the anterior ribcage of the patient;

subcutaneously implanting a first lead electrode assembly having a first electrode such that the first electrode is implanted in a position generally parallel to and adjacent the sternum on the anterior chest of the patient;

without using fluoroscopy to implant the subcutaneous defibrillator; and

coupling the canister and the first lead electrode assembly.

12. The method of claim 11, further comprising subcutaneously implanting a second lead electrode assembly having a second electrode such that the second electrode is implanted in a position to the left of the heart, and coupling the second lead electrode assembly to the canister.

13. The method of claim 12, wherein each of the first and second electrodes is a generally curvelinear electrode having a length in the range of 2-10 centimeters and a diameter in the range of 1-5 millimeters, and wherein each of the first and second lead electrodes are implanted such that their length is generally parallel to the sternum of the patient.

14. The method of claim 12, wherein the canister is inactive, and the subcutaneous defibrillator is configured for therapy delivery between the first electrode and the second electrode.

15. The method of claim 12, wherein the canister is active, and the subcutaneous defibrillator is configured for therapy delivery using the following configurations:

between the canister and the first electrode;

between the canister and the second electrode; and

between the canister and both the first and second lead electrodes connected in common.

16. The method of claim 12, wherein at least one of the first lead electrode and the second lead electrode includes each of a shock delivery electrode and a separate sensing electrode.

17. The method of claim 12, wherein the first lead electrode comprises the first electrode as a shock electrode and at least one sensing electrode electrically isolated from the first electrode.